Different Interdialytic Intervals and Cardiorespiratory Fitness in Patients Undergoing Hemodialysis
- PMID: 38407848
- PMCID: PMC11168819
- DOI: 10.2215/CJN.0000000000000435
Different Interdialytic Intervals and Cardiorespiratory Fitness in Patients Undergoing Hemodialysis
Abstract
Key Points:
This is the first study exploring differences in cardiorespiratory fitness assessed with cardiopulmonary exercise testing between the 2-day and the 3-day interdialytic interval.
The 3-day interdialytic interval was associated with further impaired cardiorespiratory fitness.
This effect was predominantly driven by excess fluid accumulation during the extra interdialytic day.
Background: Long interdialytic interval in thrice-weekly hemodialysis is associated with excess cardiovascular and all-cause mortality risk. Impaired cardiorespiratory fitness is a strong predictor of mortality in hemodialysis. This study investigated differences in cardiorespiratory fitness assessed with cardiopulmonary exercise testing (CPET) between the end of the 2-day and the 3-day interdialytic interval.
Methods: A total of 28 hemodialysis patients, randomized in two different sequences of evaluation, underwent CPET and spirometry examination at the end of the 2-day and the 3-day intervals. The primary outcome was the difference in oxygen uptake at peak exercise (VO2peak [ml/kg per minute]) assessed with CPET. Volume status was assessed with interdialytic weight gain, lung ultrasound, bioimpedance spectroscopy, and inferior vena cava measurements. A total of 14 age-matched and sex-matched controls were also evaluated. Comparisons of changes in parameters of interest were performed with paired or independent t-tests or relevant nonparametric tests, as appropriate. Bivariate correlation analyses and generalized linear mixed models were used to examine associations between changes in CPET parameters and volume indices.
Results: Hemodialysis patients at the end of both 2-day and 3-day intervals presented lower values in all major CPET parameters than controls. VO2peak (ml/kg per minute) was significantly higher at the end of the 2-day than the 3-day interval (15.2±4.2 versus 13.6±2.8; P < 0.001); the results were similar for VO2peak (ml/min) (1188±257 versus 1074±224; P < 0.001) and VO2peak (% predicted) (58.9±9.2 versus 52.3±8.6; P < 0.001). Numerical but no statistically significant differences were detected in VO2 anaerobic threshold (ml/kg per minute) and VO2 anaerobic threshold (ml/min) between the two time points. Maximal work load (90.1±23.2 versus 79.3±25.1; P < 0.001), exercise duration, heart rate at peak exercise, and oxygen pulse also showed lower values at the end of the 3-day interval. Forced expiratory volume in 1-second levels were similar between the two evaluations. Generalized linear mixed model analysis, including interdialytic weight gain as random covariate, attenuated the observed differences in VO2peak (ml/kg per minute). Changes in bioimpedance spectroscopy–derived overhydration indexes were moderately correlated with changes of VO2peak (ml/kg per minute).
Conclusions: The 3-day interval was associated with further impairment of VO2 at peak exercise. This effect was predominantly driven by excess fluid accumulation during the extra interdialytic day.
Trial registration: ClinicalTrials.gov NCT05557929.
Conflict of interest statement
A. Papagianni reports Honoraria: Baxter Hellas E.P.E., Genesis Pharma Hellas, and GlaxoSmithKline A.E.B.E. P. Sarafidis reports Consultancy: AstraZeneca, Bayer, Healthink, Innovis Pharma, Menarini, Primeview, and Recor Medical; Research Funding: AstraZeneca, Boehringer, Elpen Pharmaceuticals, and Servier; Honoraria: Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Genesis Pharma, Menarini, Peervoice, Sanofi, Springer, and Winmedica; and Advisory or Leadership Role: Council Member, European Renal Association; Editorial Board Member for
Figures




Similar articles
-
Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.Int Urol Nephrol. 2025 Mar;57(3):897-906. doi: 10.1007/s11255-024-04260-w. Epub 2024 Oct 28. Int Urol Nephrol. 2025. PMID: 39467956
-
Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients.Am J Kidney Dis. 2016 Nov;68(5):772-781. doi: 10.1053/j.ajkd.2016.06.017. Epub 2016 Aug 18. Am J Kidney Dis. 2016. PMID: 27545351
-
Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis.Clin J Am Soc Nephrol. 2015 Apr 7;10(4):630-8. doi: 10.2215/CJN.08180814. Epub 2015 Jan 29. Clin J Am Soc Nephrol. 2015. PMID: 25635033 Free PMC article.
-
The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.J Am Soc Nephrol. 2018 May;29(5):1372-1381. doi: 10.1681/ASN.2017101102. Epub 2018 Mar 28. J Am Soc Nephrol. 2018. PMID: 29592914 Free PMC article. Review.
-
Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?Am J Nephrol. 2015;41(4-5):400-8. doi: 10.1159/000435842. Epub 2015 Jun 27. Am J Nephrol. 2015. PMID: 26139107 Review.
Cited by
-
Management of volume load for patients undergoing hemodialysis via WeChat and home monitoring in China: a protocol for a cluster-randomized trial.BMC Nephrol. 2025 Feb 6;26(1):58. doi: 10.1186/s12882-024-03932-0. BMC Nephrol. 2025. PMID: 39910544 Free PMC article.
References
-
- United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2022.
-
- ERA Registry. ERA Registry Annual Report 2021. Amsterdam UMC, location AMC, Department of Medical Informatics; 2023.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical